Back to Brevan Howard Capital Management LP Brevan Howard Capital Management LP

SAVASAVA

Showing 1 of 2 quarters

Position history for Brevan Howard Capital Management LPBrevan Howard Capital Management LP's holdings in FILANA THERAPEUTICS INC

No. Brevan Howard Capital Management exited its SAVA (Filana Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 15,629 shares worth $193,018. Brevan Howard Capital Management first reported SAVA in Q2 2024 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$29.43
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used